Professionals
Education and documentation.
SIRIAM LAB works with physicians, therapists and other healthcare professionals across Europe. This section collects the documentation, training and educational material maintained by the institute.
7
Education modules
8
Documentation packs
31
Indexed segments
Clinical protocols
Structured routines per product family, describing region, frequency, quantity and documentation of use.
Available on verificationClinical training
Postgraduate training decks, read slide by slide inside the platform with a touchable mind map and presenter navigation.
AvailableEducational videos
Short recorded modules on surface landmarks, field delimitation and application technique.
In preparationIngredients
The Platform Ingredient Atlas: thirty-five searchable sheets with platform role, rationale, pharmaceutical notes and evidence level.
AvailableScientific literature
A curated reading list on segmental anatomy, dorsal rami and neurocutaneous organisation.
In preparationDownloads
Reference sheets, composition indices, patient explanation cards and QR label packs.
AvailableTraining
Practice-based sessions covering the atlas, the protocol structure and documentation discipline.
By arrangementContinuing education
A modular programme under development with European practice partners.
In preparationPractice dashboard
A single view of your protocols
A verified practice workspace is in preparation: saved atlas views, protocol sheets per patient cohort, documentation templates and versioned material.
—
Saved atlas views
—
Active protocols
8
Documentation packs
Ingredients
Platform Ingredient Atlas
Every ingredient used across the SIRIAM formulations is documented once, in one format. Search the atlas and open a sheet for its platform role, scientific rationale, pharmaceutical considerations and evidence classification.
18-001
MSM
MSM (Methylsulfonylmethane)
Structural & Dermal Support Core · Evidence B–C
18-002
Magnesium Chloride
Magnesium Chloride (MgCl₂)
Structural & Dermal Support Core · Evidence B–C
18-003
D-Panthenol
D-Panthenol (Provitamin B5)
Structural & Dermal Support Core · Evidence A–B
18-004
Vitamin E
Full Spectrum Natural Vitamin E (Mixed Tocopherols)
Structural & Dermal Support Core · Evidence A–B
18-005
Silicea Gel
Silicea Gel (Colloidal Silica Gel)
Structural & Dermal Support Core · Evidence B–C
18-006
Copaiba Oil
Copaiba Oil (Copaifera spp.)
Structural & Dermal Support Core · Evidence B
18-007
PEA
Palmitoylethanolamide (PEA)
Release Core · Evidence A–B (oral evidence); C (topical evidence)
18-008
Boswellia serrata
Boswellia serrata Extract
Release Core · Evidence A–B (oral evidence); C (topical evidence)
18-009
Ruta graveolens
Ruta graveolens Extract
Release Core · Evidence C
18-010
Arnica montana
Arnica montana Extract
Release Core · Evidence A–B (topical evidence)
18-011
Ginkgo biloba
Ginkgo biloba Leaf Extract
Release Core · Evidence A–B (oral evidence); C (topical evidence)
18-012
Bacopa monnieri
Bacopa monnieri Extract
Integration Core · Evidence A–B (oral evidence); C (topical evidence)
18-013
Blue Lotus
Nymphaea caerulea (Blue Lotus) Extract
Integration Core · Evidence C–D
18-014
Betaine (TMG)
Betaine (Trimethylglycine, TMG)
Integration Core · Evidence A (physiological and oral evidence); B (topical dermatological evidence)
18-015
Niacinamide
Niacinamide (Vitamin B3)
Integration Core · Evidence A
18-016
Melissa officinalis
Melissa officinalis Extract (Lemon Balm)
Regional Signature Components · Evidence A–B (herpes topical evidence); B (oral evidence); C (regional neurodermal application)
18-017
Gelsemium sempervirens
Gelsemium sempervirens
Regional Signature Components · Evidence D
18-018
Rhodiola rosea
Rhodiola rosea Extract
Regional Signature Components · Evidence A–B (oral evidence); C (topical evidence)
18-019
Hypericum perforatum
Hypericum perforatum Extract (St. John's Wort)
Regional Signature Components · Evidence A (oral evidence); A–B (topical wound-healing evidence); C (regional neurodermal application)
18-020
Chelidonium majus
Chelidonium majus Extract (Greater Celandine)
Regional Signature Components · Evidence B–C (topical dermatological evidence); C (experimental evidence); C–D (regional neurodermal application)
18-021
Frankincense
Frankincense (Boswellia carterii / Boswellia sacra Essential Oil)
Regional Signature Components · Evidence B–C
18-022
Myrrh
Myrrh (Commiphora myrrha Essential Oil / Resin Extract)
Regional Signature Components · Evidence B–C
18-023
Carbo vegetabilis
Carbo vegetabilis
Regional Signature Components · Evidence D
18-024
α-Bisabolol
α-Bisabolol (Levomenol)
Regional Signature Components · Evidence A–B
18-025
Syn®-Ake
Syn®-Ake (Dipeptide Diaminobutyroyl Benzylamide Diacetate)
Regional Signature Components · Evidence B (cutaneous topical evidence); C (experimental neurophysiology); C (regional neurodermal application)
18-026
Solidago virgaurea
Solidago virgaurea Extract (Goldenrod)
Regional Signature Components · Evidence B (oral evidence); C (topical evidence); C (regional neurodermal application)
18-027
Berberis vulgaris
Berberis vulgaris Extract (Barberry)
Regional Signature Components · Evidence A–B (oral berberine evidence); C (topical evidence); C (regional neurodermal application)
18-028
Castor Oil
Castor Oil (Ricinus communis Seed Oil)
Regional Signature Components · Evidence A–B
18-029
Squalane
Squalane
Regional Signature Components · Evidence A
18-030
Sepia officinalis
Sepia officinalis
Regional Signature Components · Evidence D
18-031
Staphysagria
Staphysagria (Delphinium staphisagria)
Regional Signature Components · Evidence D
18-032
Aesculus hippocastanum
Aesculus hippocastanum Extract (Horse Chestnut)
Regional Signature Components · Evidence A–B (oral vascular evidence); B (topical evidence); C (regional neurodermal application)
18-033
Magnesium Bisglycinate
Magnesium Bisglycinate
Regional Signature Components · Evidence A (oral evidence); C (topical evidence); C (regional neurodermal application)
18-034
Coenzyme Q10
Coenzyme Q10 (Ubiquinone)
Regional Signature Components · Evidence A (oral evidence); A–B (topical dermatological evidence); C (regional neurodermal application)
18-035
Taurine
Taurine
Regional Signature Components · Evidence A (oral physiological evidence); B (topical dermatological evidence); C (regional neurodermal application)
Metamere tart
One segment, six metameric expressions.
Dermatome, myotome, sclerotome, viscerotome, micro-angiotome and neurotome for every segment from C0 to S5.
Professional mode
The metamere tart is protected.
The metameric reading is the heart of osteopathic segmental reasoning and is reserved for practitioners trained in the underlying theory. Enter your professional code to continue.
Educational roadmap
What is being prepared
Educational material is published progressively. Each item is listed with its current stage.
- AvailableProtocol documentationStructured routines per family, released to verified healthcare professionals.
- In preparationAtlas seminarsPractice sessions on surface landmarks, field delimitation and documentation discipline.
- In preparationRecorded modulesShort educational modules covering the six atlas layers and their clinical vocabulary.
- PlannedContinuing education programmeA modular curriculum developed with European practice partners.
Collaboration
Request professional access
Documentation and training are provided on request to verified healthcare professionals.
Access to professional material requires verification of professional status. Material is educational and does not constitute clinical guidance.
Knowledge graph
Related knowledge
Protocols, training material and research connected to the professional channel.
Formulation
Knowledge article